Dogs with epilepsy who received cannabidiol as part of a clinical trial had a reduction in the frequency of seizures.
Results from a phase 3 study reveal Cannabidiol (CBD) cuts seizures by almost 50% in children with Dravet syndrome.
Genetic testing can help identify children at risk of epilepsy, in addition to identifying new genetic mutations associated with the condition. Using CBD based medications can also help reduce seizures in children with epilepsy.
The effect cannabidiol has on Lennox-Gastaut syndrome may be explained by the drug-drug interaction between CBD and anti-seizure medication.
Many cannabis users don't know how much THC or CBD is considered an effective dose.
Vaping cannabis products with rich THC content leads to drug-seeking behaviors in animal models.
A new study reports a single dose of the cannabis extract CBD can help reduce brain function abnormalities in those with psychosis. The findings provide evidence of how cannabidiol acts in the brain to help reduce psychotic symptoms.
Hemp oil reduced mechanical pain sensitivity 10-fold within seven hours in mice with chronic postoperative neuropathic pain.
A new study considers the medical benefits of using marijuana to help treat epilepsy which can not be controlled with standard anticonvulsants.
CBD does not appear to reduce experimental pain intensity but does make the experience of pain less unpleasant.
Cannabidiol (CBD) appears to slow the growth of glioblastoma brain cancer cells in both animal and human cell lines. CBD's anti-cancer actions target mitochondria, causing them to dysfunction and release harmful reactive oxygen species. Cancer cells treated with CBD exhibited significant decreases in mitochondrial activity.
A new study reports cannabidiol, a marijuana derivative, is effective at reducing seizure frequency in children and adults with treatment resistant epilepsy.
